[ { "@graph" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#pubinfo" } ] } ], "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#Head" }, { "@graph" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_13884", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#association", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_13884" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "https://identifiers.org/drugbank:DB00489" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "\"SORINE (sotalol hydrochloride) tablets are contraindicated in patients with: Sinus bradycardia, sick sinus syndrome, second and third degree AV block, unless a functioning pacemaker is present Congenital or acquired long QT syndromes Cardiogenic shock or decompensated heart failure Serum potassium <4 mEq/L Bronchial asthma or related bronchospastic conditions Hypersensitivity to sotalol For the treatment of AFIB/AFL, SORINE (sotalol hydrochloride) tablets are also contraindicated in patients with: Baseline QT interval >450 ms Creatinine clearance <40 mL/min For the treatment of AFIB/AFL or ventricular arrhythmias Sinus bradycardia, 2 nd rd 4 Congenital or acquired long QT syndrome ( 4 Serum potassium <4 mEq/L( 4 Cardiogenic shock, decompensated heart failure ( 4 Bronchial asthma or related bronchospastic conditions ( 4 Hypersensitivity to sotalol ( 4 For the treatment of AFIB/AFL also contraindicated for: QT interval >450 ms ( 4 Creatinine clearance <40 mL/min ( 4\"" } ], "https://w3id.org/biolink/vocab/provided_by" : [ { "@id" : "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "https://schema.org/MedicalContraindication" } ] }, { "@id" : "https://identifiers.org/drugbank:DB00489", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] } ], "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ] } ], "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-08-23T12:23:16.631+02:00" } ], "http://purl.org/dc/terms/creator" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ { "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ { "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "VSHPKdmtZp4YPGIzA5Vilm3iE46WumMcSAEqbDV9Pen8Q7CHQDPZLPhwuP3jRFizxYx+WOnLVaF/kPls8usdKif2zqEh6YYcJFmdBfFOtvQ4UQyqqKOkWw9Xjvk1HbrrIUSJqNb0AeZcZnut2WEbxXTDYdFSFwbgR6sC4CNcCMA=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs" } ] } ], "@id" : "http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#pubinfo" } ]